What sector does JEIL PHARMACEUTICAL CO.,LTD belong to?

JEIL PHARMACEUTICAL CO.,LTD operates in the Pharmaceuticals sector, specifically the Pharmaceuticals industry, and is listed on the US markets.

What is the current share price of 271980?

As of the latest available quote, 271980 traded at ₩10,100.00. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of 271980?

JEIL PHARMACEUTICAL CO.,LTD has a price-to-earnings (P/E) ratio of about 6.29. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of 271980?

The market capitalisation of JEIL PHARMACEUTICAL CO.,LTD is approximately ₩201.38B.

Is JEIL PHARMACEUTICAL CO.,LTD profitable?

For its latest reported financial year, JEIL PHARMACEUTICAL CO.,LTD recorded a net profit margin of about 5.64%.

What is the return on equity (ROE) of 271980?

JEIL PHARMACEUTICAL CO.,LTD has a return on equity (ROE) of about 11.08%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of 271980?

Over the past 52 weeks, 271980 has traded between a low of ₩8,810.00 and a high of ₩19,290.00.

JEIL PHARMACEUTICAL CO.,LTD

271980 KRX Pharmaceuticals Pharmaceuticals

KOSPI

₩10,100.00

-0.59%

Delayed · cached 15 min

Fair value analysis

271980

JEIL PHARMACEUTICAL CO.,LTD

₩10,100.00

Close used for this calculation

₩27,078.92Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

55/100

Profitability19/25

Returns11/25

Balance Sheet3/25

Efficiency22/25

Growth20/25

Good

Quality radar

Consensus fair value

₩27,078.92

Below FV

▲ +168.1% against the close used

Model range ₩14,144.70 – ₩103,790.00

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩14,144.70Fair value₩27,078.92Bull₩103,790.00

FairClose

52-week traded range

52W low ₩9,230.0052W high ₩17,390.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

JEIL PHARMACEUTICAL CO.,LTD closed at ₩10,100.00, 62.7% below the consensus fair value of ₩27,078.92 drawn from 9 valuation models.

Financial DNA score 55/100 — Good. P/E of 6.3x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₩31,857.68

+215.4%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Number

₩22,826.56

+126.0%

√(22.5 × EPS × BVPS)

EPS=1605, BVPS=14428.57

Graham Formula

₩103,790.00

+927.6%

EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate

g=20%, FD=3.3%

P/E Fair Value

₩32,100.00

+217.8%

EPS × 20x (sector P/E)

EPS=1605, Sector P/E=20x

Peter Lynch (PEG)

₩48,150.00

+376.7%

EPS × Growth% (PEG = 1 is fair)

EPS=1605, g=30%

EV/EBITDA

₩14,144.70

+40.0%

(EBITDA × 18x − Net Debt) ÷ Shares

EBITDA=20.7B

Book Value (P/B)

₩18,324.29

+81.4%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=14428.57, ROE=11.1%, g=6%, r=10%

Reverse DCF

₩10,100.00

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: -9% | Historical: 35.7%

Margin of Safety

₩35,732.67

+253.8%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=47643.56, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer